2R8-22920-19781
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 502 / IA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-10
-
2021-04-17
Survey response — day 14, dose 1MedDRA: Diarrhoea, Fatigue, Headache — Feeling: FairFree text: Diarrhea, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
- 2021-04-23
- 2021-04-26
- 2021-04-27
- 2021-05-06
- 2021-05-29
- 2021-06-05
- 2021-07-22
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Cough, Headache, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Headache fever congestion coughing no smell or tasteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-21 | Successful 2021-10-25 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — day 14, dose 1
Symptoms: Diarrhea, headache, fatigue
Release 10 — 6 months, dose 2
Symptoms: Headache fever congestion coughing no smell or taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release